[apinstein]

I call bunk.

There are many thousands of biotech companies, the vast majority of which do not sell drugs that treat chronic diabetes.

Any one of them would love to sell a diabetes drug that cures diabetes.

Either this researcher only courted a few companies that already sell diabetes treatments, who unsurprisingly didn't want to fund him (does Comcast fund startups that help you avoid buying cable? NO!) or there is something else about his research that made people not want to continue with it.